Bremelanotide (PT-141)
Hormonal
Bremelanotide is a melanocortin receptor agonist FDA-approved for hypoactive sexual desire disorder.
Libido EnhancementNauseaFlushingSubcutaneous (SubQ)Sexual HealthHormonal
Community
0
Tracking
0
Doses Logged
1mg PRN
Common Dose
—
Adverse Rate
All dosages:1mg PRN1.75mg PRN2mg PRN
Reported Adverse Effects
No adverse effects reported yet
Community Consensus
No consensus claims yet — be the first to contribute
Literature
No studies linked yet — know of one? Share it in the discussion
Discussion
No discussion yet — be the first to share your experience